Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284563 · ClinicalTrials.gov registry record · Phase 2
Ultralow Dose PET Imaging for 18F-NaF Uptake
A Phase 2 study of Healthy Volunteer and Arthritis, sponsored by Akiva Mintz.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT07284563: Recruiting Phase 2 study of Healthy Volunteer and Arthritis, sponsored by Akiva Mintz.
NCT07284563 is a Phase 2 study of Healthy Volunteer and Arthritis that is actively recruiting participants, run by Akiva Mintz. The registered enrollment target is 200 participants, roughly in line with the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07284563, a Phase 2 study of Healthy Volunteer and Arthritis, is actively recruiting participants, sponsored by Akiva Mintz.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET imaging) technique for increased bone turnover that is found in diseases such as cancer, trauma, infection, arthritis, and other benign diseases of bone detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called Fluorine-18 (18F)-sodium fluoride (NaF) and be imaged on a new type of high sensitivity PET scanner for up to 3 hours.
Primary Outcome
Measurement of signal-to-noise ratio for image quality assessment across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: SNR (unitless, numeric ratio)
Conditions Studied
Interventions
- DRUG 18F-NaF
Study Locations (2)
New Jersey
- Nuclear Imaging Institute - Englewood
- Nuclear Imaging Institute - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2030-06-30 |
| Phase | Phase 2 |
What NCT07284563 shows while recruiting
NCT07284563 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target.
The record links to 5 conditions, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which 18F-NaF is the first listed.
NCT07284563 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07284563 about?
NCT07284563 is a clinical study titled "Ultralow Dose PET Imaging for 18F-NaF Uptake". The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET imaging) technique for increased bone turnover that is found in diseases such as cancer, trauma, infection, arthritis, and other benign diseases of bone detection and monitoring. The mai...
What is the current status of trial NCT07284563?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-09-01. Estimated completion is 2030-06-30.
What conditions does trial NCT07284563 study?
This clinical trial studies the following conditions: Healthy Volunteer, Arthritis, Bone and Joint Infection, Bone Alteration, Bone and Joint Cancer.
What interventions are being tested in trial NCT07284563?
The interventions under investigation include: 18F-NaF (DRUG).
Who is sponsoring clinical trial NCT07284563?
This trial is sponsored by Akiva Mintz, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07284563 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07284563's enrollment target sits among peer trials
200 15th of 112 higher than 94 of 112 other Healthy Volunteer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging of 18F-FDG Uptake
RECRUITING · Phase 2
-
Ultralow Dose PET Imaging for PSMA Expression
RECRUITING · Phase 2
-
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
COMPLETED · Phase 2
-
Healthy Volunteer Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI